Cargando…
Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
TTR (transthyretin) amyloidoses are diseases characterized by the aggregation and extracellular deposition of the normally soluble plasma protein TTR. Ex vivo and tissue culture studies suggest that tissue damage precedes TTR fibril deposition, indicating that early events in the amyloidogenic casca...
Autores principales: | Manral, Pallavi, Reixach, Natàlia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293901/ https://www.ncbi.nlm.nih.gov/pubmed/25395306 http://dx.doi.org/10.1042/BSR20140155 |
Ejemplares similares
-
Amyloidogenicity assessment of transthyretin gene variants
por: Grether, Nicolai B., et al.
Publicado: (2022) -
Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
por: Frangolho, Ana, et al.
Publicado: (2020) -
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
por: Sacino, Amanda N, et al.
Publicado: (2013) -
Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System
por: Buxbaum, Joel N., et al.
Publicado: (2017) -
Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases
por: Park, Gil Yong, et al.
Publicado: (2019)